Fundraising Fox

BlinkBio

Stony Brook, US · Founded 2009 · Delaware corporation

Biotech

Founders & leadership

CG
Colin GoddardExecutive
JS
James SchulzExecutive

Board

VM
Viren MehtaBoard director
DR
Douglas ReedBoard director
MG
Michael GarganoBoard director
GS
Geoff SmithBoard director
MS
Mark SimonBoard director
AL
Alan LewisBoard director
KD
Kapil DhingraBoard director

Reported raises · per SEC filings

Form D private placements

$27.8M disclosed across 8 rounds · 2012–2019

▶$525KraisedJul 2019 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael GarganoDirector
  • Jutta WannerExecutive Officer
  • Viren MehtaDirector
  • Geoff SmithDirector
  • Colin GoddardExecutive Officer, Director
Offering amount
$525K
Amount sold
$525K
Sales commissions
$27.5K
Placement agents
Noble Life Science Partners
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedApr 2019 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Maneesh PingleExecutive Officer
  • Viren MehtaDirector
  • Michael GarganoDirector
  • Geoff SmithDirector
  • Colin GoddardExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$1.3M
Sales commissions
$47.5K
Placement agents
Noble Life Science Partners
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$808.4KraisedJun 2018 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Colin GoddardExecutive Officer, Director
  • Michael GarganoDirector
  • Maneesh PingleExecutive Officer
  • Viren MehtaDirector
  • Geoff SmithDirector
Offering amount
$20M
Amount sold
$808.4K
Sales commissions
$55.5K
Placement agents
Noble Life Science Partners
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.1MraisedJul 2017 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael GarganoDirector
  • Maneesh PingleExecutive Officer
  • Viren MehtaDirector
  • Geoff SmithDirector
  • Colin GoddardExecutive Officer, Director
Offering amount
$19.1M
Amount sold
$19.1M
Minimum investment
$50K
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedAug 2015 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas ReedDirector
  • Michael GarganoDirector
  • Geoff SmithDirector
  • Colin GoddardExecutive Officer, Director
Offering amount
$5M
Amount sold
$1M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedOct 2014 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoff SmithDirector
  • Michael GarganoDirector
  • Douglas ReedDirector
  • Viren MehtaDirector
  • Colin GoddardExecutive Officer, Director
Offering amount
$4M
Amount sold
$4M
First sale
Oct 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedMay 2014 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas ReedDirector
  • Colin GoddardExecutive Officer, Director
  • Geoff SmithDirector
  • Michael GarganoDirector
Offering amount
$1M
Amount sold
$1M
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50KraisedFeb 2012 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark SimonDirector
  • Colin GoddardExecutive Officer, Director
  • Alan LewisDirector
  • Viren MehtaDirector
  • Kapil DhingraDirector
  • Michael GarganoDirector
  • James SchulzExecutive Officer
Offering amount
$441K
Amount sold
$50K
Minimum investment
$25K
First sale
Jan 2012
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

BlinkBio Receives Funding from The Florida Institute - FinSMEsfinsmes.com · Mar 2017Florida Institute Funds Jupiter-based BlinkBioprnewswire.com · Mar 2017BlinkBio Announces Exclusive Agreement With The Scripps Research Institute Providing Targeting Technology For Use In Blinkbio’s Tunable Drug Conjugates Platform - BioSpacebiospace.com · Nov 2016

Frequently asked questions

How much funding has BlinkBio raised?
BlinkBio has disclosed $27.8M raised across 8 rounds.
Where is BlinkBio headquartered?
BlinkBio is headquartered in Stony Brook, US.